FibroBiologics FBLG
NASDAQ FBLG
$1.44 +0.15 (+11.63%)
As of: Aug 21, 2026 · 3:59 PM EDT

FibroBiologics (FBLG) EPS (Basic) (2023 - 2026)

FibroBiologics (FBLG) posted quarterly EPS (Basic) of -$0.89 for Q2 2026, up 63.24% year-over-year from -$0.54 in Q2 2025, and up 55.75% on a QoQ basis from -$2.0 in Q1 2026.

FibroBiologics (FBLG) EPS (Basic) (2023 - 2026) Analysis & Trends

FibroBiologics has reported EPS (Basic) for 4 years, with the latest figure at -$0.89 in Q2 2026.

  • EPS (Basic) for Q2 2026 came in at -$0.89, up 63.24% year-over-year; the trailing twelve-month figure through Jun 2026 was -$3.79 (up 44.69% YoY), and the FY2025 annual result was -$11.48, down 69.07% from the prior year.
  • EPS (Basic) grew to -$0.89 in Q2 2026, from -$2.0 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $0.55 in Q2 2024 and troughed at -$6.88 in Q4 2023.
  • A 4-year average of -$2.39 and a median of -$1.94 in 2024 frame the typical range for EPS (Basic).
  • The widest annual swing landed in 2024, when EPS (Basic) jumped 135.87%; it then slumped 1124.18% in 2025.
  • A 4-year view of EPS (Basic) shows it stood at -$6.88 in 2023, then surged by 72.61% to -$1.89 in 2024, then jumped by 34.35% to -$1.24 in 2025, then advanced by 28.39% to -$0.89 in 2026.
  • Per Business Quant data, the three most recent EPS (Basic) figures were -$0.89 in Q2 2026, -$2.0 in Q1 2026, and -$1.24 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 12.62
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 7.59
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.23
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -0.72
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.18
10 FibroBiologics 8.97 Mn 8.97 Mn - -0.64

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.89
Mar 31, 2026 -2.00
Dec 31, 2025 -1.24
Sep 30, 2025 -3.65
Jun 30, 2025 -2.41
Mar 31, 2025 -2.71
Dec 31, 2024 -1.89
Sep 30, 2024 -0.30
Jun 30, 2024 0.55
Mar 31, 2024 -5.43
Dec 31, 2023 -6.88
Sep 30, 2023 -1.55
Jun 30, 2023 -1.53
Mar 31, 2023 -3.53